Company intelligence / Profile preview

Héma-Québec

Ownership: Private
Development stage: Commercial

Overview

Héma‑Québec ensures the safe collection and supply of blood components and other human-origin biological products to hospitals in Quebec. It manages donor recruitment and screening; collects whole blood/plasma/platelets/tissues/milk; processes these under strict regulatory standards; distributes them to healthcare institutions. It also operates public banks for cord blood stem cells and mothers’ milk.

Therapeutic areas: OtherImmunologyHematology
Modalities: Blood products (whole blood, plasma, platelets)Human tissue (corneas, skin, bones, heart valves, tendons)Stem cells (cord blood)Mothers' milk
Industry: Non-Academic Healthcare

Drug pipeline

1 asset

HyQvia

Commercial

Indications: Primary immunodeficiency, Secondary immunodeficiency

Partnerships

Collaborates with Quebec hospitals and health authoritiesCoordinates with Canadian Blood Services on national supply issues

Beyond the preview

Go deeper on Héma-Québec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Héma-Québec.

Explore the full profile